Role of Respiratory Viral Infections in Airflow Obstruction After Hematopoietic Cell Transplantation
Open Access
- 25 September 2026
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (9) , e70467
Abstract
Background: Respiratory viral infections (RVIs) in allogeneic hematopoietic cell transplant (allo‐HCT) recipients can cause airflow obstruction (AFO). Despite this risk, the impact of community‐acquired RVI on PFTs in pediatric patients after allo‐HCT remains unclear. Objective: The study determines the role of RVI in the development of AFO post‐transplant among survivors of allo‐HCT. Study Design: This retrospective study analyzed St. Jude patients undergoing allo‐HCT between 2003–2020. AFO was defined by z ‐scores and forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio expressed as lower limit of normal (LLN). Baseline parameters were obtained before allo‐HCT, and Year 1 parameters within 425 days post allo‐HCT. Spirometry measures were calculated using the global lung function Initiative (GLI) calculator. Bivariate and multivariate logistic regression identified risk factors for AFO following allo‐HCT. Results: A total of 397 patients were included, with a median age of 12.7 years. RVI occurred in 13% of patients within the first 100 days after transplantation. AFO developed in 12% of patients. Among those with AFO, 68% had a baseline FEV1/FVC ratio above the LLN, and 11% had a history of lower respiratory tract infection (LRTI) ( p < 0.05). The median time from transplant to RVI was shorter in patients with AFO (12 vs. 34 days). A baseline LLN value was a significant predictor of AFO. However, after adjusting for known covariates, RVI was not independently associated with AFO risk. Conclusion: RVIs within 100 days of allo‐HCT did not significantly affect AFO following transplant in pediatric patients.Keywords
Funding Information
- American Lebanese Syrian Associated Charities
This publication has 9 references indexed in Scilit:
- Impact of Respiratory Viral Infections in Transplant RecipientsJournal of the Pediatric Infectious Diseases Society, 2024
- Outcome of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant RecipientsTransplantation Proceedings, 2024
- Approach to hematopoietic cell transplant candidates with respiratory viral detectionFrontiers in Pediatrics, 2024
- Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomesBlood Advances, 2022
- Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantationRespiratory Medicine, 2021
- Long‐term morbidity of respiratory viral infections during chemotherapy in children with leukaemiaPediatric Pulmonology, 2019
- Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant RecipientsTransplantation and Cellular Therapy, 2019
- Lung Function after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Longitudinal Study in a Population-Based CohortTransplantation and Cellular Therapy, 2013
- Airflow Decline after Myeloablative Allogeneic Hematopoietic Cell Transplantation: The Role of Community Respiratory VirusesThe Journal of Infectious Diseases, 2006